NSA2P7

Across TCGA pan-cancer cohorts, NSA2P7 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of NSA2P7’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where NSA2P7 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types NSA2P7 is over-expressed in tumor.

COAD, KIRC, and LIHC are the cancer types where NSA2P7 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in NSA2P7 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	II,III,IV	+0.644	<.001	10	view →
KIRC	Male	All	+0.499	<.001	9	view →
LIHC	Female	II,III,IV	+0.354	<.001	6	view →
LUAD	Male	II,III,IV	+0.406	.040	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

NSA2P7–COAD

Open the COAD breakdown →